Polyrizon PLRZ
NASDAQ PLRZ
$9.20 +0.05 (+0.55%)
As of: Oct 21, 2026 · 11:21 AM EDT

Polyrizon (PLRZ) Convertible Debt (2024)

Updated

Analysis

Polyrizon (PLRZ) Convertible Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.72 Bn 236.75 Bn 4.88 Bn
2 Abbott Laboratories 171.89 Bn 142.32 Bn 7.27 Bn
3 Danaher 162.78 Bn 146.59 Bn 3.61 Bn
4 Intuitive Surgical 152.59 Bn 132.01 Bn 1.96 Bn
5 Medtronic 119.68 Bn 84.93 Bn 6.34 Bn
6 Stryker 114.12 Bn 100.23 Bn 4.50 Bn
7 Boston Scientific 65.64 Bn 60.41 Bn 3.85 Bn
8 Becton Dickinson 53.61 Bn 50.76 Bn 2.32 Bn
9 Edwards Lifesciences 50.94 Bn 34.95 Bn 1.35 Bn
10 Polyrizon 6.26 Mn -26.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 718,000.00
API Access

Polyrizon Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=PLRZ&period=max&api_key=YOUR_API_KEY